Supernus Pharmaceuticals Inc SUPN Income Statements

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Supernus Pharmaceuticals Inc (SUPN)
Supernus Pharmaceuticals Inc (SUPN) Financials

Supernus Pharmaceuticals Inc (SUPN)

36.57

-0.42

(-1.14%)

Closed November 30 4:00PM

Delayed by 15 minutes

36.57

0.00

(0.00%)

After Hours: 3:59PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Revenue	167.84M	155.41M	134.77M	154.34M	164.52M	144.74M	172.68M	176.71M
Operating Income	32.44M	5.18M	-17.59M	8.14M	-996k	-3.15M	22.57M	40.85M
Pre Tax Income	35.14M	9.02M	-17.13M	9.89M	990k	243k	26.3M	44.94M
Net Income	25.48M	16.95M	-831k	-15.98M	1.18M	124k	19.92M	38.5M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	32.44M	5.18M	-17.59M	8.14M	-996k	-3.15M	22.57M	40.85M
EBITDA	53.85M	25.78M	3.14M	30.03M	40.84M	17.6M	43.29M	60.95M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Revenue	215M	302.24M	408.9M	392.76M	520.4M	586.31M	667.75M	609.04M
Operating Income	54.22M	99.54M	144.44M	148.57M	173.7M	86.03M	46.12M	-5.27M
Pre Tax Income	50.37M	100.62M	140.18M	147.49M	168.65M	73.18M	60.74M	2.77M
Net Income	91.22M	57.28M	110.99M	113.06M	126.95M	53.42M	60.71M	1.32M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	1.825	1.116	2.122	2.152	2.401	1.003	1.119	0.024
EBIT	53.53M	99.25M	144.44M	148.57M	173.7M	86.03M	46.12M	-5.27M
EBITDA	56.62M	107.64M	151.54M	155.23M	193.7M	118.62M	131.67M	99.78M

Supernus Pharmaceuticals

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions